J Schölmerich
- Gastroenterology top 10%
- Genetics top 10%
- Inflammatory Bowel Disease 4
-
- Microscopic Colitis 4
- Autoimmune and Inflammatory Disorders 2
-
- Colorectal Cancer Treatments and Studies 3
-
- Systemic Lupus Erythematosus Research 3
-
- Parvovirus B19 Infection Studies 2
-
- Dermatological and COVID-19 studies 2
-
- Lung Cancer Treatments and Mutations 2
- Cited by
- GastroenterologyGeneticsEpidemiology
In The Last Decade
J Schölmerich
17 papers receiving 663 citations
Peers
Comparison fields: 5 of 80
- Gastroenterology 58
- Genetics 251
- Epidemiology 238
- Neurology 50
- Immunology 127
Countries citing papers authored by J Schölmerich
This map shows the geographic impact of J Schölmerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Schölmerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Schölmerich more than expected).
Fields of papers citing papers by J Schölmerich
This network shows the impact of papers produced by J Schölmerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Schölmerich. The network helps show where J Schölmerich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Schölmerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 9 | |
| 2 | 2009 | 10 | |
| 3 | 2008 | 118 | |
| 4 | 2008 | 3 | |
| 5 | 2008 | 18 | |
| 6 | 2006 | 4 | |
| 7 | 2004 | 0 | |
| 8 | 2002 | 36 | |
| 9 | 2001 | 1 | |
| 10 | 2001 | 4 | |
| 11 | 1998 | 80 | |
| 12 | 1998 | 8 | |
| 13 | Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. | 1996 | 83 |
| 14 | 1996 | 245 | |
| 15 | 1996 | 24 | |
| 16 | Early detection of graft dysfunction after orthotopic liver transplantation in man by serum and biliary bile acid analysis. | 1996 | 14 |
| 17 | [A new type of ANCA in sera of patients with ulcerative colitis: effects of therapy and disease severity on serum titer]. | 1992 | 5 |
| 18 | [Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy]. | 1987 | 21 |
About J Schölmerich
J Schölmerich is a scholar working on Rheumatology, Hepatology and Physical Therapy, Sports Therapy and Rehabilitation, having authored 18 papers that have together received 683 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (4 papers), Microscopic Colitis (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Systemic Lupus Erythematosus Research (3 papers), Parvovirus B19 Infection Studies (2 papers), Autoimmune and Inflammatory Disorders (2 papers), Dermatological and COVID-19 studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Gastroenterology (58 citations), Genetics (251 citations) and Epidemiology (238 citations). J Schölmerich has collaborated with scholars based in Germany, Italy and Estonia. Frequent co-authors include Werner Falk, Tilo Andus, E Aschenbrenner, R Daig, M Gierend, G. Lock, Rainer H. Straub, Ulrike Strauch, Florian Obermeier and F Bataille. Their work appears in journals such as Gut, European Journal of Cancer and Journal of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.